Cocoa

cardiac arrhythmias, anxiety disorders

Methylxanthine-sensitive individuals with pre-existing cardiac arrhythmias or anxiety disorders may experience symptom exacerbation at high cocoa intake. Standard caffeine class contraindications apply at lower confidence for cocoa due to its lower caffeine content per serving compared to coffee.

Patients taking irreversible MAO inhibitors (phenelzine, tranylcypromine) should be counseled regarding potential tyramine and phenylethylamine content in chocolate. No published case report specifically implicating cocoa or chocolate in MAOI hypertensive crises has been identified.

No cocoa-specific hepatic safety data have been published. Patients with significant hepatic impairment may experience prolonged methylxanthine effects from heavy cocoa consumption.

Heavy dark chocolate consumption (200–300 g daily of 70%+ cocoa) contributes 80–240 mg caffeine toward the recommended ≤200 mg/day pregnancy limit. Pregnant individuals should count dark chocolate toward total daily caffeine intake. Theobromine teratogenicity observed in rabbits at ≥125 mg/kg/day — far above human dietary exposure.

Dark chocolate is not recommended as a primary food for young children on the basis of heavy metal content. Latin American-origin cocoa products carry higher cadmium loads. Disproportionate health risk has been noted for Black and Hispanic children due to compounding environmental lead exposures.

Any cocoa or chocolate ingestion by companion animals warrants immediate veterinary evaluation. A documented case of chocolate ingestion in a Corgi (88.3 mg/kg body weight) produced severe tachycardia, tremors, seizures, and prolonged neurological sequelae.